dacarbazine has been researched along with Atypical Lipomatous Tumor in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, C; Chamberlain, F; Gennatas, S; Huang, P; Jones, RL; Thway, K | 1 |
| Demetri, GD; Elias, A; Hamm, J; Hensley, ML; Jones, RL; Knoblauch, R; Maki, RG; McCarthy, S; Milhem, M; Parekh, T; Patel, S; Schuetze, SM; Van Tine, BA; von Mehren, M; Wang, G | 1 |
| Charlson, J; Chawla, SP; D'Amato, G; Demetri, GD; Forscher, C; Hensley, ML; Kaiser, P; Knoblauch, R; Livingston, M; Maki, RG; McCarthy, S; Parekh, T; Patel, S; Reed, DR; Rushing, D; Ryan, CW; Seth, R; Singh, A; von Mehren, M; Wang, G | 1 |
| Dean, A; Demetri, GD; Elias, A; Ganjoo, K; Hensley, ML; Jones, RL; Khokhar, NZ; Knoblauch, RE; Maki, RG; Milhem, M; Parekh, TV; Park, YC; Patel, SR; Schuetze, SM; Spira, A; Staddon, A; Tawbi, H; Van Tine, BA; von Mehren, M | 1 |
| Bauer, S; Blay, JY; Camargo, V; Chawla, S; Chmielowski, B; Choy, E; D'Adamo, D; Demetri, GD; Gelderblom, H; Grignani, G; Guo, M; Hohenberger, P; Italiano, A; Le Cesne, A; Maki, RG; Patel, SR; Rha, SY; Schöffski, P | 1 |
| Woll, PJ; Young, RJ | 1 |
| Romero, D | 1 |
| Bay, JO; Blay, JY; Bui-Nguyen, B; Chevreau, C; Coindre, JM; Cupissol, D; Fargeot, P; Fayette, J; Guillemet, C; Mathoulin-Pelissier, S; Penel, N; Rios, M; Rolland, F; Thyss, A | 1 |
| Bui-Nguyen, B; Italiano, A; Toulmonde, M | 1 |
| Bui, NB; Coindre, JM; Maree, D; Trojani, M | 1 |
| Moriyama, N; Muranaka, K; Tanase, K | 1 |
| Fujii, E; Kasai, A; Kobayashi, K; Komada, F; Nakanishi, M; Onishi, H; Otsuji, A; Watanabe, M; Yasuda, M; Yokoyama, N | 1 |
| Haft, H; Wang, GC | 1 |
3 review(s) available for dacarbazine and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Pharmacotherapy for liposarcoma: current and emerging synthetic treatments.
Topics: Antineoplastic Agents; Clinical Trials, Phase III as Topic; Dacarbazine; Disease-Free Survival; Doxorubicin; Furans; Humans; Ketones; Liposarcoma; Neoplasm Recurrence, Local; Progression-Free Survival | 2021 |
[Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines].
Topics: Antineoplastic Agents; Dacarbazine; Deoxycytidine; Dioxoles; Docetaxel; Doxorubicin; Gemcitabine; Humans; Ifosfamide; Leiomyosarcoma; Liposarcoma; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tetrahydroisoquinolines; Trabectedin | 2010 |
[Retrovesical liposarcoma: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colostomy; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Liposarcoma; Magnetic Resonance Imaging; Male; Pelvic Exenteration; Pelvic Neoplasms; Urinary Diversion; Vincristine | 1998 |
5 trial(s) available for dacarbazine and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
Topics: Administration, Intravenous; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Progression-Free Survival; Time Factors; Trabectedin; Young Adult | 2018 |
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
Topics: Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Leiomyosarcoma; Liposarcoma; Male; Survival Analysis; Trabectedin | 2019 |
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Dioxoles; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Survival Rate; Tetrahydroisoquinolines; Trabectedin; Young Adult | 2016 |
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Furans; Humans; Ketones; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Neoplasm Grading; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Ifosfamide; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Sarcoma; Survival Rate; Treatment Outcome; Young Adult | 2009 |
5 other study(ies) available for dacarbazine and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Eribulin in soft-tissue sarcoma.
Topics: Antineoplastic Agents; Dacarbazine; Female; Furans; Humans; Ketones; Leiomyosarcoma; Liposarcoma; Male; Soft Tissue Neoplasms | 2016 |
Sarcoma: Eribulin--a welcomed advance.
Topics: Antineoplastic Agents; Dacarbazine; Female; Furans; Humans; Ketones; Leiomyosarcoma; Liposarcoma; Male; Soft Tissue Neoplasms | 2016 |
Liposarcoma: patterns of tumor differentiation following induction chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Liposarcoma; Male; Methotrexate; Radiotherapy, High-Energy; Soft Tissue Neoplasms; Thigh; Vincristine | 1984 |
[A case of metastatic liposarcoma originating in the retroperitoneum successfully treated with combination chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Humans; Liposarcoma; Lung Neoplasms; Remission Induction; Retroperitoneal Neoplasms; Vincristine | 1999 |
Metastatic liposarcoma of the brain with response to chemotherapy: case report.
Topics: Brain Neoplasms; Dacarbazine; Doxorubicin; Female; Humans; Leg; Liposarcoma; Middle Aged; Soft Tissue Neoplasms | 1988 |